Montserrat Orti-Bonfill

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Clinical features and survival analysis of cutaneous metastases from visceral cancers: A multicenter retrospective study.

Clinical features and survival analysis of cutaneous metastases from visceral cancers: A multicenter retrospective study.

Journal: JAAD international

Published: June 08, 2026

Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.

Effectiveness and Safety of Janus Kinase Inhibitors in Adults Aged ≥ 50 Years With Moderate-To-Severe Atopic Dermatitis and Substantial Cardiovascular Comorbidity: A Multicenter Real-World Study.

Journal: International journal of dermatology

Published: January 10, 2026

Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Journal: The Australasian journal of dermatology

Published: June 27, 2025

Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort.

Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort.

Journal: International journal of dermatology

Published: April 20, 2025

Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities.

Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities.

Journal: International journal of molecular sciences

Published: April 07, 2025

Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin.

Allergen-specific circulating CLA+ memory T cells stratify IL-22 response in atopic dermatitis skin.

Journal: Frontiers in immunology

Published: March 25, 2025

Predictive Factors and Optimization of Omalizumab in Chronic Spontaneous Urticaria: A Multicenter Study of 257 Patients.

Predictive Factors and Optimization of Omalizumab in Chronic Spontaneous Urticaria: A Multicenter Study of 257 Patients.

Journal: Journal of investigational allergology & clinical immunology

Published: February 14, 2025

Safety of sonidegib in elderly patients with locally advanced basal cell carcinoma: A multicentre study.

Safety of sonidegib in elderly patients with locally advanced basal cell carcinoma: A multicentre study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 07, 2024

Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study.

Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study.

Journal: Actas dermo-sifiliograficas

Published: August 01, 2024

Effectiveness and safety in the use of Janus kinase inhibitors in combination with other classic or biological systemic treatments: real-world clinical practice experience.

Effectiveness and safety in the use of Janus kinase inhibitors in combination with other classic or biological systemic treatments: real-world clinical practice experience.

Journal: Actas dermo-sifiliograficas

Published: July 23, 2024

Heterogeneous IL-9 Production by Circulating Skin-Tropic and Extracutaneous Memory T Cells in Atopic Dermatitis Patients.

Heterogeneous IL-9 Production by Circulating Skin-Tropic and Extracutaneous Memory T Cells in Atopic Dermatitis Patients.

Journal: International journal of molecular sciences

Published: July 09, 2024

Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series.

Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series.

Journal: International journal of dermatology

Published: June 05, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026